Atara Biotherapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (15)

Latest Posts

About This Stock More About This Stock
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EST
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
Morgan Stanley Turns In A Strong Report Card On Speculation
Article By: Dr. Duru
Saturday, February 17, 2018 2:03 PM EST
At the beginning of the year, I drew up a list of stocks that Morgan Stanley included in 13G filings to disclose significant stakes. The relatively strong year-to-date performance card suggests that Morgan Stanley sure knows how to speculate.
In this article: ABG, MS, DCIX, OSTK, IWM, ATRA, APTI, PFSI, ROKU, XNET, SHSP
Read
Atara Biotherapeutics Announces Proposed Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, January 3, 2018 12:45 AM EST
Atara Biotherapeutics, Inc. today announced that it has commenced an underwritten public offering of $100,000,000 of its shares of common stock.
In this article: ATRA
Read
E Atara Biotherapeutics Shares Plunge 37% On Phase 2 Trial Failure
Article By: Terry Chrisomalis
Monday, December 14, 2015 10:09 AM EST
Today Atara Biotherapeutics shares plunged by 37% after the company reported that its phase 2 trial failed to produce statistically significant results.
In this article: ATRA
Read

PARTNER HEADLINES

Latest Tweets for $ATRA

No tweets yet!